2015 annual financial data
Viking Therapeutics 2015 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -11,996,478 USD and net income was -23,403,988 USD.
Operating cash flow was -8,731,494 USD.
Get free Viking Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -11,996,478 USD
- Net income
- -23,403,988 USD
- Operating cash flow
- -8,731,494 USD